A detailed history of M&R Capital Management Inc transactions in Embecta Corp. stock. As of the latest transaction made, M&R Capital Management Inc holds 400 shares of EMBC stock, worth $8,112. This represents 0.0% of its overall portfolio holdings.

Number of Shares
400
Previous 400 -0.0%
Holding current value
$8,112
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

SELL
$15.0 - $22.17 $60 - $88
-4 Reduced 0.99%
400 $6,000
Q3 2022

Oct 03, 2022

SELL
$24.0 - $33.42 $552 - $768
-23 Reduced 5.39%
404 $11,000
Q2 2022

Jul 05, 2022

BUY
$24.78 - $33.36 $10,581 - $14,244
427 New
427 $10,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track M&R Capital Management Inc Portfolio

Follow M&R Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&R Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on M&R Capital Management Inc with notifications on news.